Full-Service Contract Research Organization

Advancing therapiesfrom protocol toglobal approval.

Phase I–IV clinical trials and BA/BE studies across India, backed by more than 20 years of scientific and operational experience.

01Protocol

Designed before it’s dosed.

Study design, feasibility and regulatory strategy are built into the protocol from the first draft, so the study is shaped for its submission from day one.

  • Protocol design
  • Feasibility
  • Regulatory strategy
02Sites

75+ sites.
125+ investigators.

A network across India for patient recruitment and site coordination, matched to each study’s population and phase.

  • Site selection
  • Patient recruitment
  • Site coordination
03Data

Monitored to GCP. Written to standard.

Trial management and GCP-compliant site monitoring keep data clean, so the reports that follow stand up to scrutiny.

  • Clinical trial management
  • GCP monitoring
  • Reporting
04Approval

Built for USFDA, EU
and TGA review.

Regulatory consulting carries molecules from the Indian clinic to regulated markets, including the questions that come after submission.

  • Regulatory consulting
  • Submission support

See the six phases

Scroll · molecule to market
Therapeutic focus
Our Strengths

Scale where it counts, rigour everywhere.

20+Years of scientific and operational experience
75+Clinical sites across India
125+Investigators in our network
I–IVTrial phases, plus BA/BE studies
See our strengths
Our Experience

Molecules taken to regulated markets.

Studies executed for USFDA, EU and TGA review, alongside dermatological, biomarker and nutraceutical programmes.
See our experience

Study conduct in India · Review abroad
CHENNAI 75+ SITES ACROSS INDIA USFDA UNITED STATES EU / EMA TGA AUSTRALIA
USFDA · EU · TGARegulated markets our studies have been run for
20+Clinical trials executed across therapeutic areas
600+Patients enrolled across nutraceutical and supplement studies
9Therapeutic indications, from oncology to gastroenterology
Leadership

Led by people who have run the studies themselves.

Bioanalytical, project management and quality assurance experience, in the same room as your study.

Mr. G. Iniyan, BD Director and Founder of Voxtur Clinical Research
BD Director & Founder

Mr. G. Iniyan

Founder of Voxtur Clinical Research, with a BTech in Chemical Engineering from Anna University. Previously with KMS Health Center, Luminol Biopharma and Micro Therapeutic Research Labs. Runs studies to TGA, USFDA and EMA guidelines.

  • 75+Trial sites built
  • 20+Clinical trials executed
Ms. Vasanthi G, Director of Project Management at Voxtur Clinical Research
Director of Project Management

Ms. Vasanthi G

MBA from Madras University. Leads project management for oncology trials, from site management through final reporting, with close adherence to industry standards.

  • 750+BA/BE studies overseen
  • 16+Years in clinical research
Ms. Padmini Ethiraj, Quality Assurance Head at Voxtur Clinical Research
Quality Assurance Head

Ms. Padmini Ethiraj

M.Sc. in Analytical & Biopharmaceutical Technology from Anna University. Oversees quality systems for bioanalytical method validation, clinical sample processing and analytical data review.

  • 10+Years in bioanalytical operations
  • LC-MS/MSGLP, USFDA, ANVISA, MoH
Voxtur Clinical Research headquarters in Chennai, India
Headquarters · East Tambaram, Chennai
About Voxtur

A trusted partner in global clinical research.

Voxtur Clinical Research supports pharmaceutical and biopharmaceutical companies with clinical trials and BA/BE studies across India, from study planning through execution and site coordination.

Our experience includes complex clinical studies, with a growing focus on oncology and other specialised research areas.

  • ICH-GCP compliant operations
  • USFDA, EU & TGA study experience
  • Oncology & specialised research
  • International client engagements
FAQ

Questions sponsors ask first.

If your question is not here, send an enquiry or call +91 98400 76926.

Voxtur Clinical Research is a clinical research company (CRO) in Chennai, India. We run clinical trials and Bioavailability / Bioequivalence (BA/BE) studies for pharmaceutical and biopharmaceutical companies. The work covers protocol design, regulatory and ethics approvals, site tie-up, patient recruitment, monitoring, data management, statistical analysis and the signed clinical study report.

Yes. Our project management team has overseen 750+ BA/BE studies. We run BA/BE studies for regulated and non-regulated markets, with bioanalytical quality systems built for USFDA, ANVISA and MoH review.

Send us the product, the indication and what the data is for. We reply with a quotation, with optional biomarkers quoted separately. Once you confirm it with a work order, we start preparing the protocol.

Every study in India runs under CDSCO / DCGI approval and ethics committee review, in line with the New Drugs and Clinical Trials Rules 2019. For sponsors filing in regulated markets, we conduct studies to ICH-GCP and prepare data and documentation for USFDA, EU and TGA review.

We match the indication to sites from our network of 75+ hospitals and site management organisations, each with a registered ethics committee, and 125+ registered investigators. We run site feasibility and investigator selection first, and the feasibility results come to you with the recommendation.

Partner With Us

Have a protocol? Let’s move it forward.

Emailiniyan@voxturglobal.com
Phone+91 98400 76926
VisitDoor No. 6, Kamarajar Salai, Selaiyur,
East Tambaram, Chennai 600 059